← FDA Drug Approvals (Drugs@FDA)

LEUPROLIDE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UBI · Approved 2024-10-17

Drug application

FDA Application #

ANDA217957

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEUPROLIDE ACETATE

Generic name

LEUPROLIDE ACETATE

Active ingredients

LEUPROLIDE ACETATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

UBI

Manufacturer

UBI Pharma Inc.

First approval

2024-10-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown